Human visceral leishmaniasis expresses Th1 pattern in situ liver lesions.
Seixas Duarte, Maria Irma; Tuon, Felipe Francisco; Pagliari, Carla; Kauffman, Monica R; Brasil, Roosecelis Araujo.
; 57(4): 332-7, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18722018
A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis.
Imaging host-Leishmania interactions: significance in visceral leishmaniasis.
Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients.
Visceral leishmaniasis from a non-endemic Himalayan region of Nepal.
Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.
Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus Syrian hamster model.
Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literature.
Regulation of immunity during visceral Leishmania infection.
Inflammation and structural changes of splenic lymphoid tissue in visceral leishmaniasis: a study on naturally infected dogs.
Glial reactivity in dogs with visceral leishmaniasis: correlation with T lymphocyte infiltration and with cerebrospinal fluid anti-Leishmania antibody titres.